Safer Opioid Supply programs: Hydromorphone prescribing in Ontario as a harm reduction intervention to combat the drug poisoning crisis
Our findings suggest that the combination of safer supply, wrap-around support, and harm reduction within primary care settings can lead to increased healthcare engagement, HIV/HCV prevention, testing, and treatment uptake, reducing the burden of infectious diseases and overdose risk. SSPs have the potential to meaningfully reduce overdose rates, address the ongoing overdose crisis, and if scaled up, influence population-level outcomes.
Authors
- Rose A. Schmidt (ORCID: https://orcid.org/0000-0002-0307-8482)
- Carol Strıke (ORCID: https://orcid.org/0000-0002-2716-3681)
- Nanky Rai (ORCID: https://orcid.org/0000-0003-4173-509X)
- Gillian Kolla (ORCID: https://orcid.org/0000-0002-5743-7153)
- Adrian Guţă (ORCID: https://orcid.org/0000-0002-1380-2016)
- Emmet O’Reilly (ORCID: https://orcid.org/0000-0002-5740-0780)
- Andrea Sereda
- Jessica Hales
Institutions
- University of Toronto (CA)
- University of Victoria (CA)
- London Health Sciences Centre (CA)
- Regent Park Community Health Centre (CA)
- Public Health Ontario (CA)
- University of Windsor (CA)
Publication Details
- Journal
- Canadian Journal of Public Health
- Published
- 2024-12-10
- DOI
- https://doi.org/10.17269/s41997-024-00979-2
- Citations
- 9
- Primary Topic
- Opioid Use Disorder Treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.89
Funders
- Ontario HIV Treatment Network